There were no correlations between standard measures of RA disease activity and proportions of Th17 (CCR6+) cells, TfH (CXCR5+) cells or CCR6+CXCR5+ memory cells at baseline visit prior to therapy initiation (Fig. 3a–c). This evidence concerns the gene CCR6 and rheumatoid arthritis.